Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ronran

ronran

posted on Jun 24, 2007 10:51AM
It has been their gameplan for some time to maintain a slightly less than 10% combined ownership (which was for their benefit in avoiding SEC reporting requirements), and until recently, that percentage had held in the mid to high 9% range. Just by recollection, however, and subject to correction from anyone who has more accurate info, I believe the last report showed that the percentage had dropped into the 8% range

As I recall in the last 10Q it was reported that S & L held 29 million shares, however PTSC also stated that a large holder had exercised warrants worth 10 million shares just after the 10Q's reporting period.


Share
New Message
Please login to post a reply